Professor Joanna Wilson

  • Professor of Molecular Genetics (Molecular Biosciences)

telephone: 01413305108
email: Joanna.Wilson@glasgow.ac.uk

R419 Level 4, Life Sciences Biomolecular Sci, Davidson Building, Glasgow G12 8QQ

Import to contacts

ORCID iDhttps://orcid.org/0000-0003-4715-2530

Research interests

Research Interests

Research in the Wilson lab is focused on the discovery of molecular pathways involved in cancer development. We aim to use this knowledge to better understand the disease processes and to exploit it for new therapeutic design.

One area of research in the laboratory concerns the analysis of the cancer-associated virus, Epstein-Barr virus (EBV).

For further information about Dr Wilson's research interests, click

Research groups

Publications

List by: Type | Date

Jump to: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 | 1997 | 1996 | 1995 | 1993 | 1992 | 1991 | 1990 | 1989 | 1986 | 1985
Number of items: 93.

2020

Voigt, S., Sterz, K. R., Giehler, F., Mohr, A.-W., Wilson, J. B. , Moosmann, A. and Kieser, A. (2020) A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. Nature Communications, 11, 685. (doi: 10.1038/s41467-020-14502-x) (PMID:32019925) (PMCID:PMC7000802)

2019

Rühl, J. et al. (2019) Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas. Journal of Clinical Investigation, 129(5), pp. 2071-2087. (doi: 10.1172/JCI125364) (PMID:30860494) (PMCID:PMC6486346)

2018

Jackson, M., Marks, L., May, G. H.W. and Wilson, J. B. (2018) The genetic basis of disease. Essays In Biochemistry, 62(5), pp. 643-723. (doi: 10.1042/EBC20170053)

Alqarni, S. and Wilson, J.B. (2018) Epstein-Barr Virus Nuclear Antigen-1, Action and Reaction as an Oncogene. International Conference on EBV and KSHV 2018, Wisconsin, USA, 28 Jul - 1 Aug 2018.

Armfield, K., Baillie, G. and Wilson, J.B. (2018) Development of Therapeutic Approaches to Targeting Epstein-Barr virus Related Malignancies. International Conference on EBV and KSHV 2018, Wisconsin, USA, 28 Jul - 1 Aug 2018.

Wilson, J. B. , Manet, E., Gruffat, H., Busson, P., Blondel, M. and Fahraeus, R. (2018) EBNA1: oncogenic activity, immune evasion and biochemical functions provide targets for novel therapeutic strategies against Epstein-Barr virus-associated cancers. Cancers, 10(4), 109. (doi: 10.3390/cancers10040109) (PMID:29642420)

AlQarni, S. et al. (2018) Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. Oncogene, 37, pp. 3998-4012. (doi: 10.1038/s41388-018-0147-x) (PMID:29691476) (PMCID:PMC6054874)

2017

Gnanasundram, S. V., Pyndiah, S., Daskalogianni, C., Armfield, K., Nylander, K., Wilson, J. B. and Fåhraeus, R. (2017) PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. Nature Communications, 8, 2103. (doi: 10.1038/s41467-017-02282-w) (PMID:29235459) (PMCID:PMC5727396)

Gao, X., Lampraki, E.-M., Al-Khalidi, S., Qureshi, M. A., Desai, R. and Wilson, J. B. (2017) N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS ONE, 12(12), e0189167. (doi: 10.1371/journal.pone.0189167) (PMID:29228057) (PMCID:PMC5724866)

Alqarni, S. and Wilson, J.B. (2017) Epstein-Barr Virus Nuclear Antigen-1, Action and Reaction as an Oncogene. European EBV Meeting, Berlin, Germany, 06-07 Jul 2017.

Armfield, K. and Wilson, J.B. (2017) Development of Therapeutic Approaches to Targeting EBV Related Disease. European EBV Meeting, Berlin, Germany, 06-07 Jul 2017.

Alqarni, S. and Wilson, J.B. (2017) Epstein-Barr Virus Nuclear Antigen-1, in a Preclinical Model for BL. Annual Microbiology Society Conference 2017, Edinburgh, UK, 03-06 Apr 2017.

Armfield, K. and Wilson, J.B. (2017) Therapeutic Approaches to Targeting EBV Related Disease. Annual Microbiology Society Conference 2017, Edinburgh, UK, 03-06 Apr 2017.

Deschamps, T. et al. (2017) Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle. Journal of General Virology, 98(2), pp. 251-265. (doi: 10.1099/jgv.0.000681) (PMID:28284242)

2016

Armfield, K., Liskamp, R. and Wilson, J.B. (2016) Therapeutic Approaches to Targetting Epstein-Barr Virus Related Disease. Structural Aspects of Infectious Disease, Cambridge, UK, 08-10 Aug 2016.

2015

Alles, J. et al. (2015) Epstein-Barr virus EBER transcripts affect miRNA-mediated regulation of specific targets and are processed to small RNA species. Non-Coding RNA, 1(3), pp. 170-191. (doi: 10.3390/ncrna1030170)

Gao, X. and Wilson, J.B. (2015) LMP1: Chronic Inflammation and Carcinogenesis. European EBV Meeting, Stockholm, Sweden, 15-16 Jun 2015.

2014

Hussain, M., Gatherer, D. and Wilson, J. B. (2014) Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. Virus Genes, 49(3), pp. 358-372. (doi: 10.1007/s11262-014-1101-9)

2013

Hussain, M. and Wilson, J.B. (2013) EBNA1 Structure Function Relationships and Protein-protein Interactions. European EBV Meeting, Amsterdam, The Netherlands, 17-18 Apr 2013.

Hussain, M. and Wilson, J.B. (2013) New paralogues and revised time line in the expansion of the vertebrate GH18 family. Journal of Molecular Evolution, 76(4), pp. 240-260. (doi: 10.1007/s00239-013-9553-4)

2012

Hussain, M., Baillie, G. , Gatherer, D. and Wilson, J.B. (2012) Investigating Molecular Interactions Between Epstein-Barr Virus Nuclear Antigen-1 and Partner Proteins. International Congress on Oncogenic Herpesviruses and Associated Diseases, Philadelphia, PA, USA, 01-05 Aug 2012.

Hussain, M., Baillie, G. , Gatherer, D. and Wilson, J.B. (2012) Investigating Molecular Interactions Between Epstein-Barr Virus Nuclear Antigen-1 and Partner Proteins. Tenovus 30th Aniversary Symposium: Molecular Mechanisms of Disease, Glasgow, UK, 6-7 Jun 2012.

2011

Hussain, M. and Wilson, J.B. (2011) EBNA-1 Structure-function Relationships and Protein-protein Interactions. European EBV Meeting 2011, Lyon, France, 16-17 Jun 2011.

Hannigan, A., Qureshi, A.M., Nixon, C., Tsimbouri, P.M. , Jones, S., Philbey, A.W. and Wilson, J.B. (2011) Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Molecular Cancer, 10(11), pp. 1-20. (doi: 10.1186/1476-4598-10-11)

Qureshi, A.M., Hannigan, A., Campbell, D., Nixon, C. and Wilson, J.B. (2011) Chitinase-like proteins are autoantigens in a model of inflammation-promoted incipient neoplasia. Genes and Cancer, 2(1), pp. 74-87. (doi: 10.1177/1947601911402681)

2010

Hussain, M. and Wilson, J.B. (2010) Exploring the Role of Epstein Barr-Virus Encoded RNA1 (EBER-1) in Innate and Adaptive Immune Response using Transgenic Mouse Models. The 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Birmingham, UK, 04-07 Sep 2010.

Qureshi, A. and Wilson, J.B. (2010) LMP1 Causes Chronic Inflammation Prior to Neoplasia in Vivo. The 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Birmingham, UK, 04-07 Sep 2010.

Qureshi, A., Hannigan, A. and Wilson, J.B. (2010) Role of Inflammation and Oxidative Stress in Epstein-Barr Virus Oncogene Induced Carcinogenesis. Keystone Symposium on Role Inflammation in Cancer, Keystone, CO, USA, 2010.

Hannigan, A. and Wilson, J.B. (2010) Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Molecular Cancer, 9(184), pp. 1-10. (doi: 10.1186/1476-4598-9-184)

Repellin, C.E., Tsimbouri, P.M. , Philbey, A.W. and Wilson, J.B. (2010) Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus. PLoS ONE, 5(2), e9092. (doi: 10.1371/journal.pone.0009092)

2008

McLean, A., Tsimbouri, P. and Wilson, J.B. (2008) Massive Overexpression of Chitnase3-like 4 (YM2), CD30 and Immunoglobulin in LMP1 Induced Inflammation Associated Carcinogenesis. 13th International EBV Symposium, Guangzgou, China, 7-10 Nov 2008.

Tsimbouri, P. , Chiou, Y.-C. and Wilson, J.B. (2008) EBERs the Small Viral Non-coding RNAs are Tumourigenic and Disturb the Interferon Response in Vivo. Beatson International Cancer Conference Cell Growth and Metabolism, Glasgow, UK, 15-18 Jun 2008.

Sanford, J. L., Mays, T. A., Varian, K. D., Wilson, J.B. , Janssen, P. M.L. and Rafael-Fortney, J. A. (2008) Truncated CASK does not alter skeletal muscle or protein interactors. Muscle and Nerve, 38(3), pp. 1116-1127. (doi: 10.1002/mus.20993)

Tsimbouri, P. , Al-Sheikh, Y., Drotar, M. E., Cushley, W. and Wilson, J.B. (2008) Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. Journal of General Virology, 89(11), pp. 2821-2832. (doi: 10.1099/vir.0.83296-0)

2007

Chiou, Y.-C., Tsimbouri, P. and Wilson, J.B. (2007) EBER1 – a Small Viral Non-coding RNA is Tumourigenic and Disturbs the Interferon Response in Vivo. Beatson International Cancer Conference, Glasgow, UK, 16-20 Jun 2007.

McLean, A. and Wilson, J.B. (2007) Proteome Changes Induced by LMP1 in Early Carcinogenesis. European Meeting on EBV and Associated Diseases, Heidelberg, Germany, 15-16 Mar 2007.

Repellin, C. and Wilson, J. B. (2007) EBER1 – Small but Influential. European Meeting on EBV and Associated Diseases, Heidelberg, Germany, 15-16 Mar 2007.

Charalambous, C.T., Hannigan, A., Tsimbouri, P. , McPhee, G.M. and Wilson, J.B. (2007) Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF prior to neoplasia. Carcinogenesis, 28(8), pp. 1839-1848. (doi: 10.1093/carcin/bgm055)

Hannigan, A., Burchmore, R. and Wilson, J. (2007) The optimization of Protocols for Proteome difference gel electrophoresis (DiGE) analysis of Preneoplastic skin. Journal of Proteome Research, 6, pp. 3422-3432. (doi: 10.1021/pr0606878)

2006

Repellin, C. and Wilson, J. B. (2006) EBER1 - Oncogenic in Vivo? 12th International EBV Symposium, Boston, MA, USA, 08-12 Jul 2006.

Tsimbouri, P. , Al-Sheikh, Y., Mclean, A., Drotar, M. and Wilson, J. B. (2006) An Evaluation of the Contribution of EBNA1 Expression to Transgenic Mouse Lymphomagenesis. 12th International EBV Symposium, Boston, MA, USA, 08-12 Jul 2006.

2005

Tsimbouri, P.M. and Wilson, J.B. (2005) A viral oncogene which induces B-cells to survive in response to IL-2. Experimental Hematology, 33(S7), p. 112. (doi: 10.1016/j.exphem.2005.05.017)

Mclean, A. and Wilson, J.B. (2005) Proteomic Analysis Dissecting the Early Stages of Carcinogenesis. 70th Cold Spring Harbor Symposium: Molecular Approaches to Controlling Cancer, Cold Spring Harbor, NY, USA, 28 May - 02 Jun 2005.

Repellin, C. and Wilson, J.B. (2005) An Oncogenic RNA? 70th Cold Spring Harbor Symposium: Molecular Approaches to Controlling Cancer, Cold Spring Harbor, NY, USA, 28 May - 02 Jun 2005.

McMillan, K., Helgerud, J., Grant, S., Newell, J., Wilson, J., Macdonald, R. and Hoff, J. (2005) Lactate threshold responses to a season of professional British youth soccer. British Journal of Sports Medicine, 39, pp. 432-436. (doi: 10.1136/bjsm.2004.012260)

Stevenson, D., Charalambous, C. and Wilson, J. (2005) Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Research, 65, pp. 8826-8835. (doi: 10.1158/0008-5472.CAN-05-0591) (PMID:16204053)

2004

Al-Sheikh, Y. and Wilson, J.B. (2004) Dissecting the Role of EBNA1 Oncogenic Potential in EµEBNA-1 Transgenic Mice. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Charalambous, C. and Wilson, J.B. (2004) The Role of LMP1 in Carcinogenesis in Vivo. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Mclean, A. and Wilson, J.B. (2004) LMP1 Transgenic Mice: a Proteomic Analysis. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Reppelin, C. and Wilson, J.B. (2004) The EBERs: Small but Influential. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Tsimbouri, P. , Drotar, M., Hill, E. and Wilson, J.B. (2004) EBNA1 Induces B-cells to Respond to IL-2 Survival Signals. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

O'Donnel, M.A., Stevenson, D., Drotar, M. and Wilson, J.B. (2004) The Role of EBV LMP1 and LMP2 in B-cell Lymphoma. In: Keystone Symposia: Mouse Models of Human Cancer, Keystone, CO, USA, 17-22 Feb 2004,

Stevenson, D., Charalambous, C. and Wilson, J.B. (2004) The Paradoxical Role of EBV LMP1 in Carcinogenesis. Keystone Symposia: Mouse Models of Human Cancer, Keystone, CO, USA, 17-22 Feb 2004.

2003

Drotar, M.E., Silva, S., Barone, E., Campbell, D., Tsimbouri, P. , Jurvansu, J., Bhatia, P., Klein, G. and Wilson, J.B. (2003) Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis. International Journal of Cancer, 106, pp. 388-395. (doi: 10.1002/ijc.11224) (PMID:12845679)

Macdiarmid, J., Stevenson, D., Campbell, D. and Wilson, J. (2003) The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis, 24, pp. 1209-1218. (doi: 10.1093/carcin/bgg070)

2002

Charalambous, C. and Wilson, J.B. (2002) Dissecting the Role of LMP1 Signalling in Epithelial Cells in Vivo. Genes and Cancer 2002, Warwick, UK, 09-11 Dec 2002.

Dabbagh, N. and Wilson, J.B. (2002) Is DNA Vaccination a Viable Approach in the Treatment of EBV Associated Tumours? DNA Vaccines 2002, Edinburgh, UK, 23-25 Oct 2002.

MacDiarmid, J., Stevenson, D. and Wilson, J.B. (2002) The Paradoxical Role of LMP1 in Carcinogenesis. 10th International Symposium on Epstein-Barr Virus and Associated Malignant Diseases, Cairns, Australia, 16-21 Jul 2002.

Tsimbouri, P. and Wilson, J.B. (2002) The Action of EBNA1 as an Oncogene in Vivo. 10th International Symposium on Epstein-Barr Virus and Associated Malignant Diseases, Cairns, Australia, 16-21 Jul 2002.

Tsimbouri, P. , Drotar, M.E., Coy, J.L. and Wilson, J.B. (2002) bcl-x(L) and RAG genes are induced and the response to IL-2 enhanced in E mu EBNA-1 transgenic mouse lymphocytes. Oncogene, 21, pp. 5182-5187. (doi: 10.1038/sj.onc.1205490)

2001

Winchester, C. and Wilson, J.B. (2001) Mouse Models of CASK Disruption. Human Genome Meeting, Edinburgh, UK, 14 Apr 2001.

Murnaghan, S. and Wilson, J.B. (2001) CASK in Palate Development. Keystone Symposia: Integration of Signalling Pathways in Development, Keystone, CO, USA, 27 Jan - 01 Feb 2001.

Wilson, J.B. and May, G.H.W. (Eds.) (2001) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology. The Humana Press Inc.: Totowa, N.J.. ISBN 9780896036901

Curran, J., Laverty, F., Campbell, D., Macdiarmid, J. and Wilson, J. (2001) Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Research, 61, pp. 6730-6738.

Macdiarmid, J. and Wilson, J.B. (2001) Separation of epidermal tissue from underlying dermis and primary keratinocyte culture. In: Wilson, J.B. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 401-410. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:401)

Tsimbouri, P. , O'Donnell, M.A. and Wilson, J.B. (2001) Selection and enrichment of B cells from lymphoid tissues. In: Wilson, J.B.,. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 411-421. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:411)

Wilson, J.B. and Drotar, M.E. (2001) Considerations in generating transgenic mice: DNA, RNA, and protein extractions from tissues–rapid and effective blotting. In: Wilson, J.B. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 361-377. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:361)

2000

Stevenson, D., Curran, J.A. and Wilson, J.B. (2000) Generation of a Murine Model of Nasopharyngeal Carcinoma, an EBV Associated Tumour. AACR Meeting: Mouse Models of Cancer, La Jolla, CA, USA, 29 Nov - 03 Dec 2000.

Stevenson, D., Laverty, H. G., Wenwieser, S., Douglas, M. and Wilson, J. B. (2000) Mapping and expression analysis of the human CASK gene. Mammalian Genome, 11(10), pp. 934-937. (doi: 10.1007/s003350010170) (PMID:11003712)

Blair, H. J., Reed, V., Gormally, E., Wilson, J. B. , Novak, J., McInnes, R. R., Phillips, S. J., Taylor, B. A. and Boyd, Y. (2000) Positioning of five genes (CASK, ARX, SAT, IMAGE cDNAs 248928 and 253949) from the human X Chromosome short arm with respect to evolutionary breakpoints on the mouse X Chromosome. Mammalian Genome, 11(8), pp. 710-712. (doi: 10.1007/s003350010141) (PMID:10920247)

O'Donnel, M.A., Cushley, W. and Wilson, J.B. (2000) Modulation of Immune Responses in Transgenic Mouse Models of EBV Lymphomagenesis. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA1 Mechanism of Action as an Oncogene. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Cuthbert, J., Curran, J.A. and Wilson, J.B. (2000) Mechanism of Oncogenesis by the Latent Membrane Protein-1 of EBV in Vivo. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

Murnaghan, S., Winchester, C. and Wilson, J.B. (2000) The Role of CASK in Mammalian Palate Development. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA-1 Action as an Oncogene. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

1998

Laverty, H. G. and Wilson, J. B. (1998) Murine CASK Is disrupted in a sex-linked cleft palate mouse mutant. Genomics, 53(1), pp. 29-41. (doi: 10.1006/geno.1998.5479) (PMID:9787075)

Caldwell, R. G., Wilson, J. B. , Anderson, S. J. and Longnecker, R. (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity, 9(3), pp. 405-411. (doi: 10.1016/S1074-7613(00)80623-8) (PMID:9768760)

1997

Nakagawa, H., Wang, T. C., Zukerberg, L., Odze, R., Togawa, K., May, G. H.W. , Wilson, J. and Rustgi, A. K. (1997) The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene, 14(10), pp. 1185-1190. (doi: 10.1038/sj.onc.1200937) (PMID:9121767)

Wilson, J. B. (1997) Transgenic mouse models of disease and Epstein-Barr virus. Epstein Barr Virus Report, 4, pp. 63-72.

1996

Wilson, J.B. , Bell, J.L. and Levine, A.J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B-cell neoplasia in transgenic mice. EMBO Journal, 15(12), pp. 3117-3126. (PMID:8670812) (PMCID:PMC450254)

McFarlane, M. and Wilson, J. B. (1996) A model for the mechanism of precise integration of a microinjected transgene. Transgenic Research, 5(3), pp. 171-177. (doi: 10.1007/BF01969706) (PMID:8673144)

1995

Nakagawa, H., Wang, T.C., Togawa, K., Zukerberg, L., Odze, R., Wilson, J.B. and Rusti, A.K. (1995) Esophageal squamous epithelial cyclin D1 oncogene expression using an epstein-barr virus promoter in transgenic mice. Gastroenterology, 108(4), A513. (doi: 10.1016/0016-5085(95)26366-7)

1993

Wilson, J.B. , Ferguson, M.W., Jenkins, N.A., Lock, L.F., Copeland, N.G. and Levine, A.J. (1993) Transgenic mouse model of X-linked cleft palate. Cell Growth and Differentiation, 4(2), pp. 67-76. (PMID:8494785)

1992

Wilson, J.B. and Levine, A.J. (1992) The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Current Topics in Microbiology and Immunology, 182, pp. 375-384. (doi: 10.1007/978-3-642-77633-5_48) (PMID:337032)

1991

Wilson, J.B. (1991) Neoplasia in transgenic mice expressing the Epstein-Barr virus latent proteins. Journal of Cellular Biochemistry, 47(S15E), p. 40. (doi: 10.1002/jcb.240470903)

Wilson, J.B. (1991) Epstein-Barr virus latent gene induced neoplasia in transgenic mice. European Journal of Cancer, 27(S3), p. 11.

1990

Wilson, J. (1990) The rapid proliferation of oncogene books. Cell, 63(2), pp. 249-250. (doi: 10.1016/0092-8674(90)90156-9)[Book Review]

Wilson, J. B. , Weinberg, W., Johnson, R., Yuspa, S. and Levine, A. J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell, 61(7), pp. 1315-1327. (doi: 10.1016/0092-8674(90)90695-B) (PMID:1694724)

1989

Voelkerding, K. V., Sandhaus, L. M., Kim, H. C., Wilson, J. , Chittenden, T., Levine, A. J. and Raska, K. (1989) Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. American Journal of Clinical Pathology, 92(2), pp. 222-8. (PMID:2547309)

Courtneidge, S. A., Read, M., Wilson, J.B. and Fried, M. (1989) Cytoplasmic interaction between pp60c-src and a truncated polyoma virus middle T antigen. Oncogene Research, 4(1), pp. 75-80.

1986

Wilson, J. B. , Hayday, A., Courtneidge, S. and Fried, M. (1986) A frameshift at a mutational hotspot in the polyoma virus early region generates two new proteins that define T-antigen functional domains. Cell, 44(3), pp. 477-487. (doi: 10.1016/0092-8674(86)90469-1) (PMID:2417729)

Fried, M., Wilson, J.B. , Williams, T. and Norbury, C. (1986) The organisation and expression of integrated Polyomavirus DNA in transformed cells. Cancer Cells, 4, pp. 309-316.

1985

Ford, M., Davies, B., Griffiths, M., Wilson, J. and Fried, M. (1985) Isolation of a gene enhancer within an amplified inverted duplication after "expression selection". Proceedings of the National Academy of Sciences of the United States of America, 82(10), pp. 3370-3374. (doi: 10.1073/pnas.82.10.3370) (PMID:2987925) (PMCID:PMC397777)

This list was generated on Wed Apr 17 09:01:53 2024 BST.
Jump to: Articles | Book Sections | Book Reviews | Edited Books | Conference or Workshop Item | Conference Proceedings
Number of items: 93.

Articles

Voigt, S., Sterz, K. R., Giehler, F., Mohr, A.-W., Wilson, J. B. , Moosmann, A. and Kieser, A. (2020) A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. Nature Communications, 11, 685. (doi: 10.1038/s41467-020-14502-x) (PMID:32019925) (PMCID:PMC7000802)

Rühl, J. et al. (2019) Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas. Journal of Clinical Investigation, 129(5), pp. 2071-2087. (doi: 10.1172/JCI125364) (PMID:30860494) (PMCID:PMC6486346)

Jackson, M., Marks, L., May, G. H.W. and Wilson, J. B. (2018) The genetic basis of disease. Essays In Biochemistry, 62(5), pp. 643-723. (doi: 10.1042/EBC20170053)

Wilson, J. B. , Manet, E., Gruffat, H., Busson, P., Blondel, M. and Fahraeus, R. (2018) EBNA1: oncogenic activity, immune evasion and biochemical functions provide targets for novel therapeutic strategies against Epstein-Barr virus-associated cancers. Cancers, 10(4), 109. (doi: 10.3390/cancers10040109) (PMID:29642420)

AlQarni, S. et al. (2018) Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. Oncogene, 37, pp. 3998-4012. (doi: 10.1038/s41388-018-0147-x) (PMID:29691476) (PMCID:PMC6054874)

Gnanasundram, S. V., Pyndiah, S., Daskalogianni, C., Armfield, K., Nylander, K., Wilson, J. B. and Fåhraeus, R. (2017) PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. Nature Communications, 8, 2103. (doi: 10.1038/s41467-017-02282-w) (PMID:29235459) (PMCID:PMC5727396)

Gao, X., Lampraki, E.-M., Al-Khalidi, S., Qureshi, M. A., Desai, R. and Wilson, J. B. (2017) N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS ONE, 12(12), e0189167. (doi: 10.1371/journal.pone.0189167) (PMID:29228057) (PMCID:PMC5724866)

Deschamps, T. et al. (2017) Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle. Journal of General Virology, 98(2), pp. 251-265. (doi: 10.1099/jgv.0.000681) (PMID:28284242)

Alles, J. et al. (2015) Epstein-Barr virus EBER transcripts affect miRNA-mediated regulation of specific targets and are processed to small RNA species. Non-Coding RNA, 1(3), pp. 170-191. (doi: 10.3390/ncrna1030170)

Hussain, M., Gatherer, D. and Wilson, J. B. (2014) Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. Virus Genes, 49(3), pp. 358-372. (doi: 10.1007/s11262-014-1101-9)

Hussain, M. and Wilson, J.B. (2013) New paralogues and revised time line in the expansion of the vertebrate GH18 family. Journal of Molecular Evolution, 76(4), pp. 240-260. (doi: 10.1007/s00239-013-9553-4)

Hannigan, A., Qureshi, A.M., Nixon, C., Tsimbouri, P.M. , Jones, S., Philbey, A.W. and Wilson, J.B. (2011) Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Molecular Cancer, 10(11), pp. 1-20. (doi: 10.1186/1476-4598-10-11)

Qureshi, A.M., Hannigan, A., Campbell, D., Nixon, C. and Wilson, J.B. (2011) Chitinase-like proteins are autoantigens in a model of inflammation-promoted incipient neoplasia. Genes and Cancer, 2(1), pp. 74-87. (doi: 10.1177/1947601911402681)

Hannigan, A. and Wilson, J.B. (2010) Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Molecular Cancer, 9(184), pp. 1-10. (doi: 10.1186/1476-4598-9-184)

Repellin, C.E., Tsimbouri, P.M. , Philbey, A.W. and Wilson, J.B. (2010) Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus. PLoS ONE, 5(2), e9092. (doi: 10.1371/journal.pone.0009092)

Sanford, J. L., Mays, T. A., Varian, K. D., Wilson, J.B. , Janssen, P. M.L. and Rafael-Fortney, J. A. (2008) Truncated CASK does not alter skeletal muscle or protein interactors. Muscle and Nerve, 38(3), pp. 1116-1127. (doi: 10.1002/mus.20993)

Tsimbouri, P. , Al-Sheikh, Y., Drotar, M. E., Cushley, W. and Wilson, J.B. (2008) Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. Journal of General Virology, 89(11), pp. 2821-2832. (doi: 10.1099/vir.0.83296-0)

Charalambous, C.T., Hannigan, A., Tsimbouri, P. , McPhee, G.M. and Wilson, J.B. (2007) Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF prior to neoplasia. Carcinogenesis, 28(8), pp. 1839-1848. (doi: 10.1093/carcin/bgm055)

Hannigan, A., Burchmore, R. and Wilson, J. (2007) The optimization of Protocols for Proteome difference gel electrophoresis (DiGE) analysis of Preneoplastic skin. Journal of Proteome Research, 6, pp. 3422-3432. (doi: 10.1021/pr0606878)

Tsimbouri, P.M. and Wilson, J.B. (2005) A viral oncogene which induces B-cells to survive in response to IL-2. Experimental Hematology, 33(S7), p. 112. (doi: 10.1016/j.exphem.2005.05.017)

McMillan, K., Helgerud, J., Grant, S., Newell, J., Wilson, J., Macdonald, R. and Hoff, J. (2005) Lactate threshold responses to a season of professional British youth soccer. British Journal of Sports Medicine, 39, pp. 432-436. (doi: 10.1136/bjsm.2004.012260)

Stevenson, D., Charalambous, C. and Wilson, J. (2005) Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Research, 65, pp. 8826-8835. (doi: 10.1158/0008-5472.CAN-05-0591) (PMID:16204053)

Drotar, M.E., Silva, S., Barone, E., Campbell, D., Tsimbouri, P. , Jurvansu, J., Bhatia, P., Klein, G. and Wilson, J.B. (2003) Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis. International Journal of Cancer, 106, pp. 388-395. (doi: 10.1002/ijc.11224) (PMID:12845679)

Macdiarmid, J., Stevenson, D., Campbell, D. and Wilson, J. (2003) The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis, 24, pp. 1209-1218. (doi: 10.1093/carcin/bgg070)

Tsimbouri, P. , Drotar, M.E., Coy, J.L. and Wilson, J.B. (2002) bcl-x(L) and RAG genes are induced and the response to IL-2 enhanced in E mu EBNA-1 transgenic mouse lymphocytes. Oncogene, 21, pp. 5182-5187. (doi: 10.1038/sj.onc.1205490)

Curran, J., Laverty, F., Campbell, D., Macdiarmid, J. and Wilson, J. (2001) Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Research, 61, pp. 6730-6738.

Stevenson, D., Laverty, H. G., Wenwieser, S., Douglas, M. and Wilson, J. B. (2000) Mapping and expression analysis of the human CASK gene. Mammalian Genome, 11(10), pp. 934-937. (doi: 10.1007/s003350010170) (PMID:11003712)

Blair, H. J., Reed, V., Gormally, E., Wilson, J. B. , Novak, J., McInnes, R. R., Phillips, S. J., Taylor, B. A. and Boyd, Y. (2000) Positioning of five genes (CASK, ARX, SAT, IMAGE cDNAs 248928 and 253949) from the human X Chromosome short arm with respect to evolutionary breakpoints on the mouse X Chromosome. Mammalian Genome, 11(8), pp. 710-712. (doi: 10.1007/s003350010141) (PMID:10920247)

Laverty, H. G. and Wilson, J. B. (1998) Murine CASK Is disrupted in a sex-linked cleft palate mouse mutant. Genomics, 53(1), pp. 29-41. (doi: 10.1006/geno.1998.5479) (PMID:9787075)

Caldwell, R. G., Wilson, J. B. , Anderson, S. J. and Longnecker, R. (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity, 9(3), pp. 405-411. (doi: 10.1016/S1074-7613(00)80623-8) (PMID:9768760)

Nakagawa, H., Wang, T. C., Zukerberg, L., Odze, R., Togawa, K., May, G. H.W. , Wilson, J. and Rustgi, A. K. (1997) The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene, 14(10), pp. 1185-1190. (doi: 10.1038/sj.onc.1200937) (PMID:9121767)

Wilson, J. B. (1997) Transgenic mouse models of disease and Epstein-Barr virus. Epstein Barr Virus Report, 4, pp. 63-72.

Wilson, J.B. , Bell, J.L. and Levine, A.J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B-cell neoplasia in transgenic mice. EMBO Journal, 15(12), pp. 3117-3126. (PMID:8670812) (PMCID:PMC450254)

McFarlane, M. and Wilson, J. B. (1996) A model for the mechanism of precise integration of a microinjected transgene. Transgenic Research, 5(3), pp. 171-177. (doi: 10.1007/BF01969706) (PMID:8673144)

Nakagawa, H., Wang, T.C., Togawa, K., Zukerberg, L., Odze, R., Wilson, J.B. and Rusti, A.K. (1995) Esophageal squamous epithelial cyclin D1 oncogene expression using an epstein-barr virus promoter in transgenic mice. Gastroenterology, 108(4), A513. (doi: 10.1016/0016-5085(95)26366-7)

Wilson, J.B. , Ferguson, M.W., Jenkins, N.A., Lock, L.F., Copeland, N.G. and Levine, A.J. (1993) Transgenic mouse model of X-linked cleft palate. Cell Growth and Differentiation, 4(2), pp. 67-76. (PMID:8494785)

Wilson, J.B. and Levine, A.J. (1992) The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Current Topics in Microbiology and Immunology, 182, pp. 375-384. (doi: 10.1007/978-3-642-77633-5_48) (PMID:337032)

Wilson, J.B. (1991) Neoplasia in transgenic mice expressing the Epstein-Barr virus latent proteins. Journal of Cellular Biochemistry, 47(S15E), p. 40. (doi: 10.1002/jcb.240470903)

Wilson, J.B. (1991) Epstein-Barr virus latent gene induced neoplasia in transgenic mice. European Journal of Cancer, 27(S3), p. 11.

Wilson, J. B. , Weinberg, W., Johnson, R., Yuspa, S. and Levine, A. J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell, 61(7), pp. 1315-1327. (doi: 10.1016/0092-8674(90)90695-B) (PMID:1694724)

Voelkerding, K. V., Sandhaus, L. M., Kim, H. C., Wilson, J. , Chittenden, T., Levine, A. J. and Raska, K. (1989) Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. American Journal of Clinical Pathology, 92(2), pp. 222-8. (PMID:2547309)

Courtneidge, S. A., Read, M., Wilson, J.B. and Fried, M. (1989) Cytoplasmic interaction between pp60c-src and a truncated polyoma virus middle T antigen. Oncogene Research, 4(1), pp. 75-80.

Wilson, J. B. , Hayday, A., Courtneidge, S. and Fried, M. (1986) A frameshift at a mutational hotspot in the polyoma virus early region generates two new proteins that define T-antigen functional domains. Cell, 44(3), pp. 477-487. (doi: 10.1016/0092-8674(86)90469-1) (PMID:2417729)

Fried, M., Wilson, J.B. , Williams, T. and Norbury, C. (1986) The organisation and expression of integrated Polyomavirus DNA in transformed cells. Cancer Cells, 4, pp. 309-316.

Ford, M., Davies, B., Griffiths, M., Wilson, J. and Fried, M. (1985) Isolation of a gene enhancer within an amplified inverted duplication after "expression selection". Proceedings of the National Academy of Sciences of the United States of America, 82(10), pp. 3370-3374. (doi: 10.1073/pnas.82.10.3370) (PMID:2987925) (PMCID:PMC397777)

Book Sections

Macdiarmid, J. and Wilson, J.B. (2001) Separation of epidermal tissue from underlying dermis and primary keratinocyte culture. In: Wilson, J.B. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 401-410. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:401)

Tsimbouri, P. , O'Donnell, M.A. and Wilson, J.B. (2001) Selection and enrichment of B cells from lymphoid tissues. In: Wilson, J.B.,. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 411-421. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:411)

Wilson, J.B. and Drotar, M.E. (2001) Considerations in generating transgenic mice: DNA, RNA, and protein extractions from tissues–rapid and effective blotting. In: Wilson, J.B. and May, G.H.W. (eds.) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology (174). The Humana Press Inc.: Totowa, N.J., pp. 361-377. ISBN 9780896036901 (doi: 10.1385/1-59259-227-9:361)

Book Reviews

Wilson, J. (1990) The rapid proliferation of oncogene books. Cell, 63(2), pp. 249-250. (doi: 10.1016/0092-8674(90)90156-9)[Book Review]

Edited Books

Wilson, J.B. and May, G.H.W. (Eds.) (2001) Epstein-Barr Virus Protocols. Series: Methods in Molecular Biology. The Humana Press Inc.: Totowa, N.J.. ISBN 9780896036901

Conference or Workshop Item

Alqarni, S. and Wilson, J.B. (2018) Epstein-Barr Virus Nuclear Antigen-1, Action and Reaction as an Oncogene. International Conference on EBV and KSHV 2018, Wisconsin, USA, 28 Jul - 1 Aug 2018.

Armfield, K., Baillie, G. and Wilson, J.B. (2018) Development of Therapeutic Approaches to Targeting Epstein-Barr virus Related Malignancies. International Conference on EBV and KSHV 2018, Wisconsin, USA, 28 Jul - 1 Aug 2018.

Alqarni, S. and Wilson, J.B. (2017) Epstein-Barr Virus Nuclear Antigen-1, Action and Reaction as an Oncogene. European EBV Meeting, Berlin, Germany, 06-07 Jul 2017.

Armfield, K. and Wilson, J.B. (2017) Development of Therapeutic Approaches to Targeting EBV Related Disease. European EBV Meeting, Berlin, Germany, 06-07 Jul 2017.

Alqarni, S. and Wilson, J.B. (2017) Epstein-Barr Virus Nuclear Antigen-1, in a Preclinical Model for BL. Annual Microbiology Society Conference 2017, Edinburgh, UK, 03-06 Apr 2017.

Armfield, K. and Wilson, J.B. (2017) Therapeutic Approaches to Targeting EBV Related Disease. Annual Microbiology Society Conference 2017, Edinburgh, UK, 03-06 Apr 2017.

Armfield, K., Liskamp, R. and Wilson, J.B. (2016) Therapeutic Approaches to Targetting Epstein-Barr Virus Related Disease. Structural Aspects of Infectious Disease, Cambridge, UK, 08-10 Aug 2016.

Gao, X. and Wilson, J.B. (2015) LMP1: Chronic Inflammation and Carcinogenesis. European EBV Meeting, Stockholm, Sweden, 15-16 Jun 2015.

Hussain, M. and Wilson, J.B. (2013) EBNA1 Structure Function Relationships and Protein-protein Interactions. European EBV Meeting, Amsterdam, The Netherlands, 17-18 Apr 2013.

Hussain, M., Baillie, G. , Gatherer, D. and Wilson, J.B. (2012) Investigating Molecular Interactions Between Epstein-Barr Virus Nuclear Antigen-1 and Partner Proteins. International Congress on Oncogenic Herpesviruses and Associated Diseases, Philadelphia, PA, USA, 01-05 Aug 2012.

Hussain, M., Baillie, G. , Gatherer, D. and Wilson, J.B. (2012) Investigating Molecular Interactions Between Epstein-Barr Virus Nuclear Antigen-1 and Partner Proteins. Tenovus 30th Aniversary Symposium: Molecular Mechanisms of Disease, Glasgow, UK, 6-7 Jun 2012.

Hussain, M. and Wilson, J.B. (2011) EBNA-1 Structure-function Relationships and Protein-protein Interactions. European EBV Meeting 2011, Lyon, France, 16-17 Jun 2011.

Hussain, M. and Wilson, J.B. (2010) Exploring the Role of Epstein Barr-Virus Encoded RNA1 (EBER-1) in Innate and Adaptive Immune Response using Transgenic Mouse Models. The 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Birmingham, UK, 04-07 Sep 2010.

Qureshi, A. and Wilson, J.B. (2010) LMP1 Causes Chronic Inflammation Prior to Neoplasia in Vivo. The 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, Birmingham, UK, 04-07 Sep 2010.

Qureshi, A., Hannigan, A. and Wilson, J.B. (2010) Role of Inflammation and Oxidative Stress in Epstein-Barr Virus Oncogene Induced Carcinogenesis. Keystone Symposium on Role Inflammation in Cancer, Keystone, CO, USA, 2010.

McLean, A., Tsimbouri, P. and Wilson, J.B. (2008) Massive Overexpression of Chitnase3-like 4 (YM2), CD30 and Immunoglobulin in LMP1 Induced Inflammation Associated Carcinogenesis. 13th International EBV Symposium, Guangzgou, China, 7-10 Nov 2008.

Tsimbouri, P. , Chiou, Y.-C. and Wilson, J.B. (2008) EBERs the Small Viral Non-coding RNAs are Tumourigenic and Disturb the Interferon Response in Vivo. Beatson International Cancer Conference Cell Growth and Metabolism, Glasgow, UK, 15-18 Jun 2008.

Chiou, Y.-C., Tsimbouri, P. and Wilson, J.B. (2007) EBER1 – a Small Viral Non-coding RNA is Tumourigenic and Disturbs the Interferon Response in Vivo. Beatson International Cancer Conference, Glasgow, UK, 16-20 Jun 2007.

McLean, A. and Wilson, J.B. (2007) Proteome Changes Induced by LMP1 in Early Carcinogenesis. European Meeting on EBV and Associated Diseases, Heidelberg, Germany, 15-16 Mar 2007.

Repellin, C. and Wilson, J. B. (2007) EBER1 – Small but Influential. European Meeting on EBV and Associated Diseases, Heidelberg, Germany, 15-16 Mar 2007.

Repellin, C. and Wilson, J. B. (2006) EBER1 - Oncogenic in Vivo? 12th International EBV Symposium, Boston, MA, USA, 08-12 Jul 2006.

Tsimbouri, P. , Al-Sheikh, Y., Mclean, A., Drotar, M. and Wilson, J. B. (2006) An Evaluation of the Contribution of EBNA1 Expression to Transgenic Mouse Lymphomagenesis. 12th International EBV Symposium, Boston, MA, USA, 08-12 Jul 2006.

Mclean, A. and Wilson, J.B. (2005) Proteomic Analysis Dissecting the Early Stages of Carcinogenesis. 70th Cold Spring Harbor Symposium: Molecular Approaches to Controlling Cancer, Cold Spring Harbor, NY, USA, 28 May - 02 Jun 2005.

Repellin, C. and Wilson, J.B. (2005) An Oncogenic RNA? 70th Cold Spring Harbor Symposium: Molecular Approaches to Controlling Cancer, Cold Spring Harbor, NY, USA, 28 May - 02 Jun 2005.

Al-Sheikh, Y. and Wilson, J.B. (2004) Dissecting the Role of EBNA1 Oncogenic Potential in EµEBNA-1 Transgenic Mice. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Charalambous, C. and Wilson, J.B. (2004) The Role of LMP1 in Carcinogenesis in Vivo. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Mclean, A. and Wilson, J.B. (2004) LMP1 Transgenic Mice: a Proteomic Analysis. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Reppelin, C. and Wilson, J.B. (2004) The EBERs: Small but Influential. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Tsimbouri, P. , Drotar, M., Hill, E. and Wilson, J.B. (2004) EBNA1 Induces B-cells to Respond to IL-2 Survival Signals. 11th International EBV Symposium, Regensberg, Germany, 20-25 Sep 2004.

Stevenson, D., Charalambous, C. and Wilson, J.B. (2004) The Paradoxical Role of EBV LMP1 in Carcinogenesis. Keystone Symposia: Mouse Models of Human Cancer, Keystone, CO, USA, 17-22 Feb 2004.

Charalambous, C. and Wilson, J.B. (2002) Dissecting the Role of LMP1 Signalling in Epithelial Cells in Vivo. Genes and Cancer 2002, Warwick, UK, 09-11 Dec 2002.

Dabbagh, N. and Wilson, J.B. (2002) Is DNA Vaccination a Viable Approach in the Treatment of EBV Associated Tumours? DNA Vaccines 2002, Edinburgh, UK, 23-25 Oct 2002.

MacDiarmid, J., Stevenson, D. and Wilson, J.B. (2002) The Paradoxical Role of LMP1 in Carcinogenesis. 10th International Symposium on Epstein-Barr Virus and Associated Malignant Diseases, Cairns, Australia, 16-21 Jul 2002.

Tsimbouri, P. and Wilson, J.B. (2002) The Action of EBNA1 as an Oncogene in Vivo. 10th International Symposium on Epstein-Barr Virus and Associated Malignant Diseases, Cairns, Australia, 16-21 Jul 2002.

Winchester, C. and Wilson, J.B. (2001) Mouse Models of CASK Disruption. Human Genome Meeting, Edinburgh, UK, 14 Apr 2001.

Murnaghan, S. and Wilson, J.B. (2001) CASK in Palate Development. Keystone Symposia: Integration of Signalling Pathways in Development, Keystone, CO, USA, 27 Jan - 01 Feb 2001.

Stevenson, D., Curran, J.A. and Wilson, J.B. (2000) Generation of a Murine Model of Nasopharyngeal Carcinoma, an EBV Associated Tumour. AACR Meeting: Mouse Models of Cancer, La Jolla, CA, USA, 29 Nov - 03 Dec 2000.

O'Donnel, M.A., Cushley, W. and Wilson, J.B. (2000) Modulation of Immune Responses in Transgenic Mouse Models of EBV Lymphomagenesis. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA1 Mechanism of Action as an Oncogene. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Cuthbert, J., Curran, J.A. and Wilson, J.B. (2000) Mechanism of Oncogenesis by the Latent Membrane Protein-1 of EBV in Vivo. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

Murnaghan, S., Winchester, C. and Wilson, J.B. (2000) The Role of CASK in Mammalian Palate Development. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA-1 Action as an Oncogene. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

Conference Proceedings

O'Donnel, M.A., Stevenson, D., Drotar, M. and Wilson, J.B. (2004) The Role of EBV LMP1 and LMP2 in B-cell Lymphoma. In: Keystone Symposia: Mouse Models of Human Cancer, Keystone, CO, USA, 17-22 Feb 2004,

This list was generated on Wed Apr 17 09:01:53 2024 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Investigation of the role of the chitinase-like proteins in arthritis and inflammation
    Tenovus Scotland
    2012 - 2013
     
  • Investigation into the mechanism of action of the Epstein-Barr virus encoded EBNA-1 in contributing to B-cell lymphoma
    Wellcome Trust
    2009 - 2010
     
  • Exploring the contribution to lymphomagenesis of EBNA-1 through its inhibition.
    Leukaemia Research Fund
    2008 - 2009
     
  • An investigation into the action of the EBV small RNAs in vivo
    Wellcome Trust
    2006 - 2010
     
  • The action of EBNA-1 and the cellular gene CJ11, resolving the conundrum
    Leukaemia Research Fund
    2005 - 2008
     
  • Analysis of EBNA-1 induced deregulation of cellular gene expression
    Leukaemia Research Fund
    2004 - 2006
     
  • EBNA-1 of Epstein-Barr virus & transcription factor LR1
    Leukaemia Research Fund
    2002 - 2005
     
  • Investigation of the hodgkins disease model (Support for projects 9879 and 9906).
    Leukaemia Research Fund
    2001 - 2005
     

Teaching

I am coordinator for the MRes degree in Biomedical Sciences. This is a masters degree tailored for the student who is interested in a research career. I am also organiser of the popular Undergraduate Level-4 and Masters Option: Cancer: Molecular and Cellular Biology and a new Masters option: Modelling Human Disease.

  • M.Res. Biomedical Sciences programme coordinator, adviser of studies, lecturer and examiner
  • New for 2016/17: M.Sc. Biomedical Sciences programme coordinator, lecturer and examiner
  • Organiser and principle lecturer and examiner of the Masters taught course ³Molecular Genetics of Disease²
  • Organiser, session leader and examiner in the masters course ³modelling human disease²
  • Organisor and lab leader in the M.Res./M.Sc. in Biomedical Sciences molecular biol. Labs.
  • Lectures and tutorials in the ³Hallmarks in cancer² course for the MSc in cancer sciences
  • L4 Cancer option ­course coordinator, principle lecturer and examiner
  • L3 mutants and model organisms - facilitator for SDLs (Genetics and MCB)
  • Tutor: L4 genetics tutorials, L4 MCB tutorials and L3 MCB problem sessions
  • HoC scholars list tutorials
  • L4 dissertation supervisor
  • L4 honours project supervisor
  • M.Res. project supervisor
  • PhD student supervisor

 

Additional information

Grant Advisory Board

  • 2006 - present: MRC - Member of College of Experts, Molecular and Cellular Medicine Board.
  • 2006 - present: Tenovus Scotland - Symposium Committee

Invited International Presentations

  • 2012: Glasgow, Scotland - 14th TENOVUS symposium planning "celebrating 30 years"
  • 2011: Lyon, France - Scientific Programme Committee: "European Meeting on EBV and Associated Diseases"
  • 2010: Birmingham, England - Scientific Programme Committee: "International Symposium on EBV and Associated Diseases"
  • 2009: Glasgow, Scotland - 13th TENOVUS symposium "Gene Expression in Development and Disease"
  • 2008: Guangzhou, China - "International Meeting on EBV and Associated Diseases"
  • 2007: Heidleberg, Germany - "European Meeting on EBV and Associated Diseases"
  • 2006: Glasgow, Scotland - 2006 onwards: co-organisor for Tenovus symposia and medal lectures
  • 2006: Glasgow, Scotland - 12th TENOVUS symposium "Stability and Regulation of Genes and Genomes"
  • 2006: Boston, USA - Selection committee for the International Meeting on EBV and Associated Diseases
  • 2005: Glasgow, Scotland - Local Organising Committee for the 34th Annual Scientific Meeting of the International Society for Experimental Hematology, Glasgow University, Glasgow
  • 2002: Cairns, Australia - "International Meeting on EBV and Associated Diseases"
  • 2002: Cairns, Australia - International Meeting on EBV and Associated Diseases
  • 2002: Glasgow, UK. - British Pharmacological Society Meeting
  • 2001: Homburg, Germany - "Signal transduction and Oncogenes"
  • 2001: London, UK - Leukemia Research Foundation Meeting
  • 2001: Paris, France - Seminar: Hôpital Saint Louis
  • 2001: Homburg, Germany - Signal transduction and Oncogenes Meeting
  • 1999: Edinburgh, UK - Co-organisation of the European EBV meeting, at the Royal Society of Edinburgh

Professional Learned Society

  • 2003 - present: SETNET - Ambassador
  • 2002 - 2006: Association for Research on Epstein-Barr Virus and Associated Diseases - Member of Governing Board

Research Fellowship

  • 1990 - 1995: Royal Society Fellowship